Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis

Nephrology Dialysis Transplantation

Volumn 27, Issue 10, 2012, Pages 3816-3822

  Zimmerman, Deborah ^a   Sood, Manish M ^b   Rigatto, Claudio ^b   Holden, Rachel M ^c   Hiremath, Swapnil ^a   Clase, Catherine M ^d  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

atrial fibrillation; hemodialysis; mortality; prevalence; stroke

Indexed keywords

ANTITHROMBOCYTIC AGENT; WARFARIN;

ADULT; AGED; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; FEMALE; HEART ATRIUM FIBRILLATION; HEMODIALYSIS; HUMAN; INCIDENCE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW;

ANTICOAGULANTS; ATRIAL FIBRILLATION; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; PREVALENCE; RENAL DIALYSIS; RISK FACTORS; STROKE; WARFARIN;

EID: 84868577117     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs416     Document Type: Review

References (39)

1. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification scheme for predicting stroke: results from the National Registry of atrial fibrillation. JAMA 2001; 285: 2864-2870
2. Holden RM, Sanfilippo AS, Hopman WM, Zimmerman D, Garland JS, Morton AR. Warfarin and aortic valve calcification in hemodialysis patients. J Nephrol 2007; 4: 417-422
3. Coates T, Kirkland GS, Dymock RB et al. Cutaneous necrosis from calcific uremic arteriolopathy. Am J Kidney Dis 1998; 32: 384-391
4. Winkelmayer WC, Patrick AR, Liu J, Brookhart MA, Setoguchi S. The increasing prevalence of atrial fibrillation among hemodialysis patients. J Am Soc Nephrol 2011; 22: 349-357
5. Elliott MJ, Zimmerman D, Holden RM. Warfarin anticoagulation in hemodialysis patients: A systematic review of bleeding risks. Am J Kidney Dis 2007; 50: 433-440
6. Wells G, Shea B, O'Connell D et al. The Newcastle-Ottawa (NOS) for assessing the quality of nonrandomized studies in meta-analysis. Ottawa Hospital Research Institute. http://www.ohri.ca/programs/clinical-epidemiology/oxford. htm
7. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188
8. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560
9. Egger M, Davey Smith G, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ 1997; 315: 629-634
10. Wizemann V, Tong L, Satayathum S et al. Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy. Kidney Int 2010; 77: 1098-1106
11. Sanchez-Perales C, Vazquez E, Garcia-Cortes MJ et al. Ischaemic stroke in incident dialysis patients. Nephrol Dial Transplant 2010; 25: 3343-3348
12. Lai HM, Aronow WS, Kalen P et al. Incidence of thromboembolic stroke and of major bleeding in patients with atrial fibrillation and chronic kidney disease treated with and without warfarin. Int J Nephrol Renovascular Dis 2009; 2: 33-37
13. Genovesi S, Vincenti A, Rossi E et al. Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients. Am J Kidney Disease 2008; 51: 255-262
14. Abe S, Yoshizawa M, Nakanishi N, Yazawa T, Yokota K, Honda M, Sloman G. Electrocardiographic abnormalities in patients receiving hemodialysis. Am Heart J 1996; 131: 1137-1144
15. Abbott KC, Trespalacios FC, Taylor AJ, Agodoa LY. Atrial fibrillation in chronic dialysis patients in the United States: risk factors for hospitalization and mortality. BMC Nephrol 2003; 4: 1-10
16. Acar G, Akcay A, Dogan E et al. The prevalence and predictors of atrial fibrillation in hemodialysis patients. Türk Kardiyol Dern Ar? 2010; 38: 8-13
17. Ansari N, Manis T, Feinfeld DA. Symptomatic atrial arrhythmias in hemodialysis patients. Renal Fail 2001; 23: 71-76
18. Atar I, Konas D, Acikel S et al. Frequency of atrial fibrillation and factors related to its development in dialysis patients. Int J Cardiol 2006; 106: 47-51
19. Bozbas H, Atar I, Yildiriri A et al. Prevalence and predictors of arrhythmia in end stage renal disease patients on hemodialysis. Renal Fail 2007; 29: 331-339
20. Chan KE, Lazarus JM, Thadhani R, Hakim RM. Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. JASN 2009; 20: 2223-2233
21. Chou CY, Kuo HL, Wang SM et al. Outcome of atrial fibrillation among patients with end-stage renal disease. Nephrol Dial Transplant 2010; 25: 1225-1230
22. To AC, Yehia M, Collings JF. Atrial fibrillation in haemodialysis patients: do the guidelines apply? Nephrology 2007; 12: 441-447
23. Fabbian F, Catalano C, Lambertini D et al. Clinical characteristics associated to atrial fibrillation in chronic hemodialysis patients. Clin Nephrol 2000; 54: 234-239
24. Jassal SV, Coulshed SJ, Douglas JF, Stout RW. Autonomic neuropathy predisposing to arrhythmias in hemodialysis patients. Am J Kidney Dis 1997; 30: 219-223
25. Krane V, Heinrich F, Meesmann M et al. Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis. Clin J Am Soc Nephrol 2009; 4: 394-400
26. Schonburg M, Ziegelhoeffer T, Weinbrenner F et al. Preexisting atrial fibrillation as predictor for late-time mortality in patients with end-stage renal disease undergoing cardiac surgery-a multicenter study. Thorac Cardiovasc Surg 2008; 56: 128-132
27. Vazquez E, Sanchez-Perales C, Lozano C et al. Comparison of prognostic value of atrial fibrillation versus sinus rhythm in patients on long-term hemodialysis. Am J Cardiol 2003; 92: 868-871
28. Vazquez-Ruiz de Castroviejo E, Sanchez-Perales C, Lozano-Carbezas C et al. Incidence of atrial fibrillation in hemodialysis patients. A prospective long-term follow-up study. Rev Esp Cardiol 2006; 58: 779-84
29. Vazquez E, Sanchez-Perales C, Garcia-Garcia F et al. Atrial fibrillation in incident dialysis patients. Kidney Int 2009; 76: 324-330
30. Wiesholzer M, Harm F, Tomasec G, Barbieri G, Putz D, Balcke P. Incidence of stroke among chronic hemodialysis patients with nonrheumatic atrial fibrillation. Am J Nephrol 2001; 21: 35-3
31. Winkelmayer WC, Liu J, Setoguchi S, Choudry NK. Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation. cJASN 2011; 6: 2662-2668
32. Phelan PJ, O'Kelly P, Hollan J et al. Warfain use in hemodialysis patients: what is the risk? Clin Nephrol 2011; 75: 204-211
33. Fujii H, Kim J, Yoshiya K, Nishi S, Fukagawa M. Clinical characteristics and cardiovascular outcomes of hemodialysis patients with atrial fibrillation: a prospective follow-up study. Am J Nephrol 2011; 34: 126-134
34. Seliger SL, Gillen DL, Longstreth Wt, Jr, Kestenbaum B, Stehman-Breen CO. Elevated risk of stroke among patients with end stage renal disease. Kidney Int 2003; 64: 603-609
35. Devereaux PJ, Anderson DR, Gardner MJ et al. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: an observational study. BMJ 2001; 323: 1218-1222
36. Wetmore JB, Mahnken JD, Rigler SK, Ellerbeck EF, Mukhopadhyay P, Spertus JA, Hou Q, Shireman TI. The prevalence of and factors associated with chronic atrial fibrillation in Medicare/Medicaid-eligible dialysis patients. Kidney Int 2012; 81: 469-476
37. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010; 137: 263-72
38. Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJGM, Lip GYH. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro heart study. Chest 2010; 138: 1093-1100
39. Fang MC, Go AS, Chang Y et al. A new risk scheme to predict warfarin-associated hemorrhage. J Am Coll Cardiol 2011; 58: 395-401.